Cynthia Jordan: TNBC Accounts for About 10–15% of All Breast Cancer Cases
Cynthia Jordan, Founder of Learn Look Locate, shared on LinkedIn:
“Triple-negative breast cancer (TNBC) accounts for about 10–15% of all breast cancer cases – but its biology makes it especially challenging. TNBC lacks estrogen, progesterone, and HER2 receptors, so it doesn’t respond to many standard targeted therapies.
That’s why research and innovation are vital. Recent advances, including immunotherapy and targeted strategies, are reshaping the way TNBC is treated – offering new hope for patients.
At Learn Look Locate, we’re proud to feature expert insights from our Medical Advisor Maryam Lustberg, Director of the Breast Center at Yale Cancer Center and Smilow Cancer Hospital. Dr. Lustberg is a leading breast medical oncologist, clinician, and researcher dedicated to advancing care and improving quality of life for patients with breast cancer.”
Cynthia Jordan
More posts featuring Cynthia Jordan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023